Publications

2024

Endocrine activity of dysfunctional adipose tissue: Cardiovascular risk and progression markers

Eiras S, González-Juanatey JR

Int J Cardiol. 2024 Apr 15;401:131816

Engineering hyaluronic acid-based nanoassemblies for monoclonal antibody delivery – design, characterization, and biological insights

López-Estévez AM, Zhang Y, Medel M, Arriaga I, Sanjurjo L, Huck-Iriart C, Abrescia NGA, Vicent MJ, Ouyang D, Torres D, José Alonso M

Nano Res. 17, 9111–9125 (2024)

Nanomedicine and Drug Delivery

Enhanced Levels of Adiposity, Stretch and Fibrosis Markers in Patients with Coexistent Heart Failure and Atrial Fibrillation

Fu X, Iglesias-Álvarez D, García-Campos A, Martínez-Monzonís MA, Almenglo C, Martinez-Cereijo JM, Reija L, Fernandez ÁL, Gonzalez-Juanatey JR, Rodriguez-Manero M, Eiras S

Cardiovasc Transl Res. 2024 Feb;17(1):13-23

Cardiovascular Area

ERNEST COST action overview on the (patho)physiology of GPCRs and orphan GPCRs in the nervous system

Birgül Iyison N, Abboud C, Abboud D, Abdulrahman AO, Bondar AN, Dam J, Georgoussi Z, Giraldo J, Horvat A, Karoussiotis C, Paz-Castro A, Scarpa M, Schihada H, Scholz N, Güvenc Tuna B, Vardjan N

Br J Pharmacol. 2024 Jun 2

Molecular Pharmacology of G protein-coupled receptors

Estimated Technological Obsolescence of Computed Tomography Equipment

Reyes-Santias F, Portela-Romero M, Cinza-Sanjurjo S, Cordova-Arevalo O, González-Juanatey JR

Acad Radiol. 2024 Mar;31(3):951-955

Cardiovascular Area